10-12 September 2018 //  Lancaster Royal Hotel, London


Eric Soller

Dr Eric Soller

Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Eric Soller, PhD, is an Entrepreneur-in-Residence at Versant Ventures, a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. He most recently launched BlueRock Therapeutics, a next-generation stem cell therapeutics company with significant backing from Versant and Bayer. Prior to joining Versant in 2016, Dr. Soller was an Associate Partner in McKinsey & Company’s New York office and a leader in the Healthcare and Corporate Finance practices. At McKinsey, he advised senior management of leading biopharma companies on a range of strategic and operational issues across marketing, sales, and clinical and corporate development. Dr. Soller holds a PhD in Mechanical Engineering with a Biomedical focus from the Massachusetts Institute of Technology (MIT), where his scientific work focused on induced organ regeneration using collagen-based scaffolds. He received his BS in Mechanical Engineering with minors in Applied Biology and Biomedical Engineering from the Rose-Hulman Institute of Technology (RHIT).


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad